跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 854 条关于
“OXB”
全部
854
临床试验
311
药物
487
机构
11
资讯
45
2个月前
OXB Selected as GMP Manufacturing Partner for Plowshare Therapies' AAV Gene Therapy Programme Targeting Rare Genetic Diseases
去年
Oxford BioMedica Achieves Full Ownership of US Subsidiary to Strengthen Global Gene Therapy Manufacturing Network
去年
Pfizer Withdraws Sickle Cell Drug Oxbryta Globally Following Safety Concerns
去年
Pfizer Withdraws Sickle Cell Drug Oxbryta After EMA Reports Deaths in Trials
2年前
NHS Approves Oxbryta for Sickle Cell Disease Following Price Reduction Agreement
去年
Pfizer's Inclacumab Fails Phase III Trial for Sickle Cell Disease, Marking Second Setback from Global Blood Therapeutics Acquisition
去年
Sickle Cell Disease Treatment Landscape Faces Challenges Despite Gene Therapy Advances
去年
FDA's Accelerated Approval Pathway Faces Scrutiny as Some Drugs are Withdrawn
去年
EMA to Review Pfizer's Oxbryta Following Patient Deaths in Clinical Trials
去年
Pfizer's Oxbryta Withdrawal Highlights Sickle Cell Disease Treatment Challenges as EMA Extends Marketing Suspension
第 1 页,共 5 页
上一页
下一页